Find out what companies around the world are saying about working with us.
Client location
Client location with testimonial
Algorithme Pharma is an important partner in our development efforts and we recommend them for any ligand-binding requirements. Bryan Tayefeh | Assistant Director Alliance Management Ionis Pharmaceuticals, Inc. Read full testimonial
We have also been very pleased with their record of timely recruitment, including ensuring an inventory of back-up study participants. Hélène Dulude, B.Pharm., Ph.D. Director, Clinical Development Locemia Solutions ULC Read full testimonial
...the communication between our teams was optimal, from the first protocol draft to the delivery of final report. Maxime Ranger President and CEO gIcare pharma inc Read full testimonial
It was easy to work with them and they were always willing to take the time to discuss any concerns and respond to questions. Marie-Francoise TEMAM Associate Director, Clinical Operations Idenix, a wholly-owned subsidiary of Merck & Company Read full testimonial
I recommend this site because of the expertise and quality of trials performed. Okba Haj-Ali Saflo Clinical Research Scientist Chemo Group Read full testimonial

Algorithme Pharma has been a great partner for us, in the context of key clinical trials for our lead drug candidates. The professionalism and skills of Algorithme Pharma’s staff were crucial to the success of our Gastrointestinal Phase Ib efficacy program, which included food effect and PK evaluations. Their services were delivered as planned, with time and cost efficiencies. Their expertise in bioanalytical development and method validation has proven to be an added value for our small company.

We needed to conduct a technical Phase 1b study, which involved rectal barostat experiments. Algorithme Pharma’s team was open to put in place and acquire the expertise required to conduct such a large barostat study. They have demonstrated their ability and willingness to adapt their services to meet our needs.

This trial was the largest ever barostat study conducted (90 subjects) within the shortest timeframe (3 months). All operations relied on consistency and methodology, and Algorithme Pharma delivered the work beyond our expectations. Furthermore, subject recruitment is one of their great assets, and enabled us to complete the study within our corporate timelines.

Finally, the communication between our teams was optimal, from the first protocol draft to the delivery of final report. I would recommend Algorithme Pharma to start-up biotechnology companies such as ours, for both first-in-man trials and customized Proof-of-Concept trials, such as our barostat study.


Maxime Ranger
President and CEO
gIcare pharma inc